George Tziras
Fortune : 165 029 $ au 31/05/2026
Fortune : 165 029 $ au 31/05/2026
George Tziras currently works at Small Pharma, Inc., as Chief Executive Officer & Director from 2022, Cybin UK Ltd., as Non-Executive Director from 2015, and Cybin, Inc., as Chief Business Officer from 2025.
Mr. Tziras also formerly worked at Unilock Capital Corp., as Chief Business Officer & Director.
Mr. Tziras received his undergraduate degree from the University of Oxford and graduate degree from The Paul H.
Nitze School of Advanced International Studies.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CYBIN, INC. 0,07% | 20/02/2026 | 36 270 ( 0,07% ) | 165 029 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SMALL PHARMA INC. | Directeur Général | 20/07/2022 |
| CYBIN INC. | Corporate Officer/Principal | 23/10/2023 |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Directeur/Membre du Conseil | 01/01/2015 |
| Sociétés | Poste | Fin |
|---|---|---|
| SMALL PHARMA INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Paul H. Nitze School of Advanced International Studies
The Paul H. Nitze School of Advanced International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Health Technology |
Unilock Capital Corp.
Unilock Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Small Pharma, Inc.
Small Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuro pharmaceutical company that develops therapeutic treatments for mental health disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national